title: Phase II study of TCNU in advanced breast cancer.
authors.affiliation: Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
authors.forename: P
authors.initials: P
authors.lastname: Dombernowsky
authors.forename: M
authors.initials: M
authors.lastname: Clavel
authors.forename: J F
authors.initials: JF
authors.lastname: Smyth
authors.forename: A
authors.initials: A
authors.lastname: Howell
authors.forename: M
authors.initials: M
authors.lastname: van Glabekke
authors.forename: J
authors.initials: J
authors.lastname: Renard
authors.forename: H M
authors.initials: HM
authors.lastname: Pinedo
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D013654:Taurine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D013654:Taurine; C052991:1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea